Site|specific therapy guided by a 90|gene expression assay versus ...

Site-specific therapy guided by a 90-gene expression assay versus ...

Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a ...

Site-specific therapy guided by a 90-gene expression assay versus ...

This single-centre randomised trial showed that site-specific therapy guided by the 90-gene expression assay could improve progression-free survival

1208MO A randomized phase III trial of site-specific therapy guided ...

Site-specific treatment guided by the approved 90-gene-expression assay resulted in more therapy options, significantly improved PFS and favorable OS

Site-Specific Therapy Guided by a 90-Gene Expression Assay

Site-specific prediction by the 90-gene expression assay might provide more disease information and expand the therapeutic armamentarium in ...

Site-specific therapy in cancers of unknown primary site

... site-specific therapy guided by 90-gene expression assay profiling. Moreover, in recent years, several molecular and pathological profiling ...

The clinical utility of the 90-gene expression assay on diagnosis and ...

A randomized phase III trial (CUP001) has demonstrated that site-specific treatment guided by the 90-gene-expression assay (Canhelp-Origin Assay) ...

Gene-Expression Profiling Can Help Improve Outcomes in Cancers ...

"The use of site-specific therapy guided by GEP should be recommended and has relevance for patients with molecularly diagnosed cancers now ...

Gene Expression Assay Shows Ability to Guide Targeted Treatment ...

Patients with cancers of unknown primary had more treatment options and better outcomes when care was informed by a 90-gene expression ...

Development and Clinical Validation of a 90-Gene Expression ...

Additional studies are ongoing to further evaluate the clinical utility of this novel gene expression assay in predicting primary site and directing therapy for ...

Site-Specific and Targeted Therapy Based on Molecular Profiling by ...

Interventions RNA and DNA sequencing for selected genes was performed simultaneously to evaluate gene expression and gene alterations, ...

A phase III trial of empiric chemotherapy with cisplatin and ...

Luo et al. Annals of Oncology. 1208MO A randomized phase III trial of site-specific therapy guided by the 90-gene expression assay versus ...

Personalized Therapy Selection by Integration of Molecular Cancer ...

27. Luo Z, Liu X, Zhang X, et al: 1208MO A randomized phase III trial of site-specific therapy guided by the 90-gene expression assay versus ...

90-Gene Expression Profiling for Tissue Origin Diagnosis of Cancer ...

We validated a 90-gene expression assay and explored its potential diagnostic utility in 44 patients at Jiangsu Cancer Hospital. For each ...

Clinical validation of a 90-gene expression test for tumor tissue of ...

For each case, the 90-gene classifier analyzed the gene expression pattern of the 90 tumor-specific genes and generated similarity scores for ...

CancerTYPE ID® | Hologic

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a ...

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in ...

Endocrine therapy was noninferior to chemoendocrine therapy in the analysis of invasive disease–free survival (hazard ratio for invasive disease ...

Breast Cancer Gene Expression Tests | Tailor Your Treatment

This test looks at a set of 21 genes in cancer cells from tumor biopsy or surgery samples to get a “recurrence score,” which is a number between 0 and 100. The ...

Gene expression profiling for the diagnosis of multiple primary ...

For each clinical specimen, the tumor type predicted by the 90-gene expression assay was compared with its pathological diagnosis, with an ...

Gene Expression Analysis Using TaqMan Assays

TaqMan Gene Expression Assays · Gold-standard specificity, sensitivity, and reproducibility · Don't waste precious time optimizing your SYBR primers—get results ...

Association of a 40-Gene Expression Profile With Risk of Metastatic ...

The 40-gene expression profile (GEP) test classifies cutaneous squamous cell carcinoma tumors into low (class 1), higher (class 2A), or highest (class 2B) risk ...